This could be due to variable copy number of the TP53 gene present across samples, which would affect the TP53 MAF i.e. the tumor fraction measured using copy number analysis is based on genome wide events, which might differ from the allele frequency of point mutations especially if they are not in copy number neutral regions. This evidence concerns the gene TP53 and neoplasm.